Igor Lima Fernandes
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Igor Lima Fernandes has a total of 105 co-authors. Here are the top co-authors by number of shared publications:
- Ciro Dantas Soares
Oral Diagnosis Department, Piracicaba Dental School, University of Campinas (UNICAMP), Avenida Limeira 901, Areião, Piracicaba, São Paulo, 13414-900, Brazil.
5 shared publications - João Paulo Gonçalves de Paiva
Oral Diagnosis Department, Piracicaba Dental School, University of Campinas (UNICAMP), Avenida Limeira 901, Areião, Piracicaba, São Paulo, 13414-900, Brazil
5 shared publications - Lucas Faria Abrahao-Machado
Private Pathology Service, Laboratório Bacchi, São Paulo, Brazil
5 shared publications - Maíra Medeiros Pacheco de Andrade
Getúlio Sales Diagnósticos (GSD), Private Pathology Service, Natal, Rio Grande do Norte, Brazil
4 shared publications - Isaac Santos Araújo
Oral Diagnosis Department, Piracicaba Dental School, University of Campinas (UNICAMP), Avenida Limeira 901, Areião, Piracicaba, São Paulo, 13414-900, Brazil
3 shared publications - Luiz Miguel Ferreira
Oral Diagnosis Department, Piracicaba Dental School, University of Campinas (UNICAMP), Avenida Limeira 901, Areião, Piracicaba, São Paulo, 13414-900, Brazil
3 shared publications
Latest Publications
- 16 September 2026
- Published by Oxford University Press (OUP) in Neuro-Oncology
- Vol. 28 (10) , 2435-2448
High-grade astrocytoma with piloid features: A clinical and genomic analysis of prognostic factors using a large cohort
Background: High-grade astrocytoma with piloid features (HGAP) is a recently defined tumor type that is not well understood. Prognostic factors of clinical outcomes are not well established. Methods: Methylation profiling was performed on tumor samples, many at the National Cancer Institute (NCI) Laboratory of Pathology, and others from publicly available sources. Methylation classifier scores of ≥0.90 to the HGAP class on the NCI-Bethesda classifier version 3 were included. Clinical features were collected from the medical record. Survival analyses were performed using the Kaplan-Meier and Cox-proportional hazards methods. Results: The cohort comprised 421 patients. There were high rates of ATRX alteration (62%), CDKN2A/B homozygous loss (78%) and MGMT promoter methylation (53%). MAPK alterations were identified in 74% of evaluable samples. The median age was 46 years, and posterior fossa location was predominant (52%). The median overall survival was 88 months. Older age (P = .01) and the presence of an ATRX alteration (P = .04) were found to be negative prognostic factors. The presence of cystic features on magnetic resonance imaging (MRI) was found to be favorably prognostic (P = .01). Factors that were not significantly associated with prognosis included histologic high-grade features, CDKN2A/B homozygous deletion, MGMT promoter methylation, extent of resection, and presence of NF1 syndrome. Conclusions: This large cohort establishes relative frequencies of several important markers. Additionally, older age, the presence of an ATRX alteration, and cystic features on MRI were found to be prognostic. Our work may aid in optimizing treatment regimens for patients with this tumor type.
- 16 September 2026
- Published by Oxford University Press (OUP) in Neuro-Oncology
- Vol. 28 (10) , 2435-2448
High-grade astrocytoma with piloid features: A clinical and genomic analysis of prognostic factors using a large cohort
Background: High-grade astrocytoma with piloid features (HGAP) is a recently defined tumor type that is not well understood. Prognostic factors of clinical outcomes are not well established. Methods: Methylation profiling was performed on tumor samples, many at the National Cancer Institute (NCI) Laboratory of Pathology, and others from publicly available sources. Methylation classifier scores of ≥0.90 to the HGAP class on the NCI-Bethesda classifier version 3 were included. Clinical features were collected from the medical record. Survival analyses were performed using the Kaplan-Meier and Cox-proportional hazards methods. Results: The cohort comprised 421 patients. There were high rates of ATRX alteration (62%), CDKN2A/B homozygous loss (78%) and MGMT promoter methylation (53%). MAPK alterations were identified in 74% of evaluable samples. The median age was 46 years, and posterior fossa location was predominant (52%). The median overall survival was 88 months. Older age (P = .01) and the presence of an ATRX alteration (P = .04) were found to be negative prognostic factors. The presence of cystic features on magnetic resonance imaging (MRI) was found to be favorably prognostic (P = .01). Factors that were not significantly associated with prognosis included histologic high-grade features, CDKN2A/B homozygous deletion, MGMT promoter methylation, extent of resection, and presence of NF1 syndrome. Conclusions: This large cohort establishes relative frequencies of several important markers. Additionally, older age, the presence of an ATRX alteration, and cystic features on MRI were found to be prognostic. Our work may aid in optimizing treatment regimens for patients with this tumor type.
- Open Access
- 29 May 2026
- Published by Springer Nature in Head and Neck Pathology
- Vol. 20 (1)
Characterizing Warthin-Like Mucoepidermoid Carcinoma: Clinicopathologic Features and MAML2 Rearrangements in 14 Latin American Cases
Purpose: Warthin-like mucoepidermoid carcinoma (WL-MEC) is a low-grade variant of mucoepidermoid carcinoma (MEC), characterized by a multicystic growth pattern and dense lymphoid stroma, histologically mimicking Warthin tumor (WT). Few cases have been reported, limiting understanding of this variant. We aimed to provide a comprehensive clinical, histopathologic, and molecular analysis of new WL-MEC cases. Methods and Results: Fourteen WL-MEC cases from Brazil, Guatemala, and Mexico were analyzed. Clinicopathologic features (patient demographics, tumor location, AFIP grading, follow-up, recurrence), histological characteristics (architectural patterns, inflammatory infiltrate, epithelial components, invasion), and immunohistochemical profiles (CK5/6, p63, p40, CK7, CK14, Ki67, HER2) were assessed. MAML2 generearrangements and HER2 amplification were evaluated by fluorescence in situ hybridization (FISH). All 14 cases showed MAML2 rearrangement (100%), confirming the diagnosis, while HER2 amplification was absent in all 9 cases tested. Conclusions: This study provides new insights into the clinicopathological and molecular features of WL-MEC, confirming its typical presentation (parotid gland, middle-aged females), low-grade behavior, and favorable prognosis after surgical excision. Detection of MAML2 rearrangement is a valuable diagnostic tool for distinguishing WL-MEC from WT.
- 29 May 2026
- Published by Springer Nature in Head and Neck Pathology
- Vol. 20 (1)
Open AccessCharacterizing Warthin-Like Mucoepidermoid Carcinoma: Clinicopathologic Features and MAML2 Rearrangements in 14 Latin American Cases
Purpose: Warthin-like mucoepidermoid carcinoma (WL-MEC) is a low-grade variant of mucoepidermoid carcinoma (MEC), characterized by a multicystic growth pattern and dense lymphoid stroma, histologically mimicking Warthin tumor (WT). Few cases have been reported, limiting understanding of this variant. We aimed to provide a comprehensive clinical, histopathologic, and molecular analysis of new WL-MEC cases. Methods and Results: Fourteen WL-MEC cases from Brazil, Guatemala, and Mexico were analyzed. Clinicopathologic features (patient demographics, tumor location, AFIP grading, follow-up, recurrence), histological characteristics (architectural patterns, inflammatory infiltrate, epithelial components, invasion), and immunohistochemical profiles (CK5/6, p63, p40, CK7, CK14, Ki67, HER2) were assessed. MAML2 generearrangements and HER2 amplification were evaluated by fluorescence in situ hybridization (FISH). All 14 cases showed MAML2 rearrangement (100%), confirming the diagnosis, while HER2 amplification was absent in all 9 cases tested. Conclusions: This study provides new insights into the clinicopathological and molecular features of WL-MEC, confirming its typical presentation (parotid gland, middle-aged females), low-grade behavior, and favorable prognosis after surgical excision. Detection of MAML2 rearrangement is a valuable diagnostic tool for distinguishing WL-MEC from WT.
- Open Access
- 19 March 2026
- Published by Springer Nature in Head and Neck Pathology
- Vol. 20 (1) , 34
Characterization of CD8 + and CD68 + Microenvironment and PDL1 Expression in HPV-related Multiphenotypic Sinonasal Carcinoma
Aim: To characterize the expression of CD8 + T cells, CD68 + macrophages, and PDL1 in HPV-related multiphenotypic sinonasal carcinoma (HMSC) and evaluate their correlations with clinical outcomes. Materials and Methods: This retrospective cross-sectional study analyzed 27 HMSC cases. Clinical and histopathological data were obtained from medical records. Immunohistochemical expression of CD8 and CD68 was assessed quantitatively and qualitatively in stromal and intratumoral compartments. PDL1 expression was evaluated using the Combined Positive Score (CPS). HPV genotyping was performed using the Anyplex II HPV28 assay. Statistical analyses included descriptive statistics, Fisher’s exact test, Chi-square test, Spearman’s correlation, Student’s t-test, Mann-Whitney U test, Kaplan-Meier survival analysis with log-rank test, and Cox proportional hazards models. Results: The cohort included 15 (55.6%) males and 12 (44.4%) females, with a mean age of 59.5 years. Most patients presented without recurrence ( n = 17, 63.0%), lymph node metastasis ( n = 22, 81.5%), or distant metastasis ( n = 23, 85.2%). HPV-33 was the predominant genotype, detected in 17 cases (63.0%). PDL1 positivity was observed in 12 tumors (44.4%) and correlated with increased CD8 + infiltration (ρ = 0.602, p < 0.01). Higher densities of CD8 + T cells and CD68 + macrophages were associated with reduced recurrence risk. Older age correlated with higher Ki67 index (ρ = 0.452, p < 0.05), lower PDL1 expression (ρ=-0.436, p < 0.05), and increased recurrence. Lymph node and distant metastases were associated with poorer disease-specific survival ( p = 0.020 and p = 0.010, respectively). Conclusions: The immune microenvironment, characterized by CD8 + and CD68 + cell density and PDL1 expression, together with patient age, appears to influence clinical outcomes in HMSC. These findings suggest that a subset of HMSC patients, particularly those with an inflamed tumor microenvironment, may be candidates for PDL1-targeted immunotherapy.
- 19 March 2026
- Published by Springer Nature in Head and Neck Pathology
- Vol. 20 (1) , 34
Open AccessCharacterization of CD8 + and CD68 + Microenvironment and PDL1 Expression in HPV-related Multiphenotypic Sinonasal Carcinoma
Aim: To characterize the expression of CD8 + T cells, CD68 + macrophages, and PDL1 in HPV-related multiphenotypic sinonasal carcinoma (HMSC) and evaluate their correlations with clinical outcomes. Materials and Methods: This retrospective cross-sectional study analyzed 27 HMSC cases. Clinical and histopathological data were obtained from medical records. Immunohistochemical expression of CD8 and CD68 was assessed quantitatively and qualitatively in stromal and intratumoral compartments. PDL1 expression was evaluated using the Combined Positive Score (CPS). HPV genotyping was performed using the Anyplex II HPV28 assay. Statistical analyses included descriptive statistics, Fisher’s exact test, Chi-square test, Spearman’s correlation, Student’s t-test, Mann-Whitney U test, Kaplan-Meier survival analysis with log-rank test, and Cox proportional hazards models. Results: The cohort included 15 (55.6%) males and 12 (44.4%) females, with a mean age of 59.5 years. Most patients presented without recurrence ( n = 17, 63.0%), lymph node metastasis ( n = 22, 81.5%), or distant metastasis ( n = 23, 85.2%). HPV-33 was the predominant genotype, detected in 17 cases (63.0%). PDL1 positivity was observed in 12 tumors (44.4%) and correlated with increased CD8 + infiltration (ρ = 0.602, p < 0.01). Higher densities of CD8 + T cells and CD68 + macrophages were associated with reduced recurrence risk. Older age correlated with higher Ki67 index (ρ = 0.452, p < 0.05), lower PDL1 expression (ρ=-0.436, p < 0.05), and increased recurrence. Lymph node and distant metastases were associated with poorer disease-specific survival ( p = 0.020 and p = 0.010, respectively). Conclusions: The immune microenvironment, characterized by CD8 + and CD68 + cell density and PDL1 expression, together with patient age, appears to influence clinical outcomes in HMSC. These findings suggest that a subset of HMSC patients, particularly those with an inflamed tumor microenvironment, may be candidates for PDL1-targeted immunotherapy.
- 9 March 2026
- Published by Wolters Kluwer Health in American Journal of Surgical Pathology
- Vol. 50 (6) , 629-641
Expanding HPV-Related Multiphenotypic Sinonasal Carcinoma Morphologic and Genotyping Profile
This study characterized a cohort of 52 cases of HPV-related multiphenotypic sinonasal carcinoma (HMSC) from Latin America, integrating clinicopathological, immunohistochemical, HPV genotyping, and prognostic data. HMSC predominantly arose in the nasal cavity (n=20/38.46%) of patients in their sixth decade, with equal sex distribution (n=26/50%) and frequent symptomatic presentation. Histopathologically, all tumors displayed epithelial surface dysplasia (n=52/100%). Most cases featured solid proliferations (n=25/48.08%) of basaloid cells (n=46/88.46%), with frequent tumor necrosis (n=41/75.85%). Perineural (n=5/9.62%) and vascular invasion (n=3/5.77%) were uncommon. Most patients underwent surgical excision (n=19/46.34%). Recurrence occurred in 15 of 42 cases (35.71%), although the majority remained disease-free at last follow-up (n=35/85.37%). Immunohistochemistry revealed diffuse p16 expression and variable positivity for squamous and myoepithelial markers. The Ki-67 proliferation index was high overall (median 50.1 [30.7 to 66.3]). HPV genotyping identified HPV 33 as the predominant subtype (n=34/65.38%), with a subset of cases demonstrating coinfections (n=9/17.30%). Survival analysis revealed excellent outcomes (5 y OS, DSS, and DFS at 90.1%, 89.7%, and 82.4%, respectively), although regional and distant metastases and HPV coinfections correlated with poorer survival. Our findings underscore the necessity of individual-subtype-specific HPV genotyping to characterize HMSC pathogenesis and refine prognostic stratification accurately.
- 9 March 2026
- Published by Wolters Kluwer Health in American Journal of Surgical Pathology
- Vol. 50 (6) , 629-641
Expanding HPV-Related Multiphenotypic Sinonasal Carcinoma Morphologic and Genotyping Profile
This study characterized a cohort of 52 cases of HPV-related multiphenotypic sinonasal carcinoma (HMSC) from Latin America, integrating clinicopathological, immunohistochemical, HPV genotyping, and prognostic data. HMSC predominantly arose in the nasal cavity (n=20/38.46%) of patients in their sixth decade, with equal sex distribution (n=26/50%) and frequent symptomatic presentation. Histopathologically, all tumors displayed epithelial surface dysplasia (n=52/100%). Most cases featured solid proliferations (n=25/48.08%) of basaloid cells (n=46/88.46%), with frequent tumor necrosis (n=41/75.85%). Perineural (n=5/9.62%) and vascular invasion (n=3/5.77%) were uncommon. Most patients underwent surgical excision (n=19/46.34%). Recurrence occurred in 15 of 42 cases (35.71%), although the majority remained disease-free at last follow-up (n=35/85.37%). Immunohistochemistry revealed diffuse p16 expression and variable positivity for squamous and myoepithelial markers. The Ki-67 proliferation index was high overall (median 50.1 [30.7 to 66.3]). HPV genotyping identified HPV 33 as the predominant subtype (n=34/65.38%), with a subset of cases demonstrating coinfections (n=9/17.30%). Survival analysis revealed excellent outcomes (5 y OS, DSS, and DFS at 90.1%, 89.7%, and 82.4%, respectively), although regional and distant metastases and HPV coinfections correlated with poorer survival. Our findings underscore the necessity of individual-subtype-specific HPV genotyping to characterize HMSC pathogenesis and refine prognostic stratification accurately.
- 29 July 2025
- Published by Springer Nature in Head and Neck Pathology
- Vol. 19 (1) , 94
Clinicopathological Profile of HPV-related Multiphenotypic Sinonasal Carcinoma: A Systematic Review
This study aimed to perform a systematic review of the clinicopathological, prognostic features, and HPV genotyping patterns of HPV-related multiphenotypic sinonasal carcinoma (HMSC). This study adhered to the PRISMA 2020 guidelines and was registered in the PROSPERO database. We included case reports, case series studies, and cohort studies of HMSC indexed in the PubMed, Web of Science, Scopus, Embase, and LILACS databases published between 2017 and 2025. Collected variables were analyzed descriptively, followed by association analyses using Fisher's and Chi-squared tests, and the Kaplan-Meier method. The quality assessment of the included studies was conducted using the Joanna Briggs Institute tools. This systematic review identified 32 studies encompassing 101 HMSC cases. The majority occurred in the nasal cavity of patients in the sixth decade of life, without significant sex predilection. Microscopically, the HMSC predominantly displayed basaloid morphology with solid and cribriform growth patterns, high mitotic activity, pleomorphism, and necrosis. Most patients underwent surgical excision and experienced no recurrence or metastasis, indicating favorable outcomes. However, treatment modality, recurrence, and distant metastasis negatively affected survival rates. HMSC cases showed strong p16 expression, variable squamous/epithelial and myoepithelial marker expression, and a high Ki67 index. HPV 33 was the most prevalent type identified. HMSC is a heterogeneous malignant lesion with excellent overall prognosis. Detection of transcriptionally active HPV through in situ hybridization or reverse transcriptase polymerase chain reaction is critical for definitive diagnosis of HMSC.
- 29 July 2025
- Published by Springer Nature in Head and Neck Pathology
- Vol. 19 (1) , 94
Clinicopathological Profile of HPV-related Multiphenotypic Sinonasal Carcinoma: A Systematic Review
This study aimed to perform a systematic review of the clinicopathological, prognostic features, and HPV genotyping patterns of HPV-related multiphenotypic sinonasal carcinoma (HMSC). This study adhered to the PRISMA 2020 guidelines and was registered in the PROSPERO database. We included case reports, case series studies, and cohort studies of HMSC indexed in the PubMed, Web of Science, Scopus, Embase, and LILACS databases published between 2017 and 2025. Collected variables were analyzed descriptively, followed by association analyses using Fisher's and Chi-squared tests, and the Kaplan-Meier method. The quality assessment of the included studies was conducted using the Joanna Briggs Institute tools. This systematic review identified 32 studies encompassing 101 HMSC cases. The majority occurred in the nasal cavity of patients in the sixth decade of life, without significant sex predilection. Microscopically, the HMSC predominantly displayed basaloid morphology with solid and cribriform growth patterns, high mitotic activity, pleomorphism, and necrosis. Most patients underwent surgical excision and experienced no recurrence or metastasis, indicating favorable outcomes. However, treatment modality, recurrence, and distant metastasis negatively affected survival rates. HMSC cases showed strong p16 expression, variable squamous/epithelial and myoepithelial marker expression, and a high Ki67 index. HPV 33 was the most prevalent type identified. HMSC is a heterogeneous malignant lesion with excellent overall prognosis. Detection of transcriptionally active HPV through in situ hybridization or reverse transcriptase polymerase chain reaction is critical for definitive diagnosis of HMSC.
- Top Cited Papers
- 8 May 2025
- Published by Springer Nature in Head and Neck Pathology
- Vol. 19 (1) , 1-13
Clinicopathological Analysis of Salivary Glands Warthin-like Mucoepidermoid Carcinoma: A Systematic Review
Purpose This systematic review summarizes the current literature on Warthin-like mucoepidermoid carcinoma (WL-MEC), highlighting its clinicopathological, immunohistochemical and molecular characteristics. Methods This study followed the Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines and was registered by PROSPERO (protocol CRD42024523598). Case reports and case series published in English on WL-MEC of major and minor salivary glands were included. The search was conducted in MEDLINE/PubMed, Scopus, Web of Science, and Embase databases in November 2024, along with a search in grey literature. Twenty-one articles met the eligibility criteria. The extracted information included clinicopathological data, immunohistochemical and molecular tests, treatment, recurrence, metastasis, follow-up, and status. The data analysis was performed descriptively, and presented as absolute and relative frequencies, and means or median for numerical variables. Results 78 WL-MEC cases were analyzed, with a female predominance observed and a wide age range, peaking in the sixth decade of life. Most cases involved the parotid gland and presented as indolent nodular masses, often asymptomatic. Histologically, the majority were low-grade tumors, with multicystic growth patterns and a lymphocytic infiltrate. Immunohistochemical analysis revealed consistent expression of p63, p40, CK5/6, and exhibited low Ki67 proliferation index (< 5%). MAML2 rearrangement was identified in all molecularly analyzed cases (n = 72/ 100%). Surgical treatment was the most common approach, which typically resulted in low recurrence rates, no distant metastasis, and favorable overall outcomes. Conclusion WL-MEC cases typically present as indolent, asymptomatic nodules in the parotid gland, often with a female predominance and a wide age range, peaking in the sixth decade of life. Surgery is the primary treatment and is associated with a favorable prognosis, characterized by low rates of recurrence and metastasis. These tumors commonly exhibit low-grade histopathological features, a multicystic pattern, and lymphocytic inflammatory infiltrate. The detection of MAML2 rearrangement, typically via FISH, is an essential diagnostic tool, emphasizing the molecular similarities between WL-MEC and conventional MEC.
- 8 May 2025
- Published by Springer Nature in Head and Neck Pathology
- Vol. 19 (1) , 1-13
Top Cited PapersClinicopathological Analysis of Salivary Glands Warthin-like Mucoepidermoid Carcinoma: A Systematic Review
Purpose This systematic review summarizes the current literature on Warthin-like mucoepidermoid carcinoma (WL-MEC), highlighting its clinicopathological, immunohistochemical and molecular characteristics. Methods This study followed the Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines and was registered by PROSPERO (protocol CRD42024523598). Case reports and case series published in English on WL-MEC of major and minor salivary glands were included. The search was conducted in MEDLINE/PubMed, Scopus, Web of Science, and Embase databases in November 2024, along with a search in grey literature. Twenty-one articles met the eligibility criteria. The extracted information included clinicopathological data, immunohistochemical and molecular tests, treatment, recurrence, metastasis, follow-up, and status. The data analysis was performed descriptively, and presented as absolute and relative frequencies, and means or median for numerical variables. Results 78 WL-MEC cases were analyzed, with a female predominance observed and a wide age range, peaking in the sixth decade of life. Most cases involved the parotid gland and presented as indolent nodular masses, often asymptomatic. Histologically, the majority were low-grade tumors, with multicystic growth patterns and a lymphocytic infiltrate. Immunohistochemical analysis revealed consistent expression of p63, p40, CK5/6, and exhibited low Ki67 proliferation index (< 5%). MAML2 rearrangement was identified in all molecularly analyzed cases (n = 72/ 100%). Surgical treatment was the most common approach, which typically resulted in low recurrence rates, no distant metastasis, and favorable overall outcomes. Conclusion WL-MEC cases typically present as indolent, asymptomatic nodules in the parotid gland, often with a female predominance and a wide age range, peaking in the sixth decade of life. Surgery is the primary treatment and is associated with a favorable prognosis, characterized by low rates of recurrence and metastasis. These tumors commonly exhibit low-grade histopathological features, a multicystic pattern, and lymphocytic inflammatory infiltrate. The detection of MAML2 rearrangement, typically via FISH, is an essential diagnostic tool, emphasizing the molecular similarities between WL-MEC and conventional MEC.
- Open Access
- 20 December 2020
- Published by Revista de Relatos de Casos do CBC in Relatos de Casos Cirúrgicos do Colégio Brasileiro de Cirurgiões
- Vol. 6 (4) , 1-5
Primary mucoepidermoid carcinoma of the thyroid
INTRODUÇÃO: O carcinoma mucoepidermoide (CME) é geralmente encontrado nas glândulas salivares, mas há relatos de envolvimento primário de outros órgãos. O primeiro caso dessa neoplasia na topografia da tireoide foi descrito em 1977. Atualmente, há 53 casos relatados na literatura, incluindo os dois casos relatados neste estudo. O MEC da tireoide é raro e geralmente tem um bom prognóstico. DESCRIÇÃO DO CASO: Neste estudo, apresentamos o relato de dois casos clínicos de CME da tireoide: uma variante não esclerosante e uma variante esclerosante com eosinofilia. Ambos ocorreram em mulheres com diagnóstico prévio de tireoidite de Hashimoto. DISCUSSÃO: Considerando o pequeno número de casos publicados, uma revisão completa da literatura de todos os casos publicados foi realizada e relacionada à nossa experiência. Os tumores raros da glândula tireoide devem sempre ser considerados como um possível diagnóstico nos nódulos tireoidianos de Bethesda III.
- 20 December 2020
- Published by Revista de Relatos de Casos do CBC in Relatos de Casos Cirúrgicos do Colégio Brasileiro de Cirurgiões
- Vol. 6 (4) , 1-5
Open AccessPrimary mucoepidermoid carcinoma of the thyroid
INTRODUÇÃO: O carcinoma mucoepidermoide (CME) é geralmente encontrado nas glândulas salivares, mas há relatos de envolvimento primário de outros órgãos. O primeiro caso dessa neoplasia na topografia da tireoide foi descrito em 1977. Atualmente, há 53 casos relatados na literatura, incluindo os dois casos relatados neste estudo. O MEC da tireoide é raro e geralmente tem um bom prognóstico. DESCRIÇÃO DO CASO: Neste estudo, apresentamos o relato de dois casos clínicos de CME da tireoide: uma variante não esclerosante e uma variante esclerosante com eosinofilia. Ambos ocorreram em mulheres com diagnóstico prévio de tireoidite de Hashimoto. DISCUSSÃO: Considerando o pequeno número de casos publicados, uma revisão completa da literatura de todos os casos publicados foi realizada e relacionada à nossa experiência. Os tumores raros da glândula tireoide devem sempre ser considerados como um possível diagnóstico nos nódulos tireoidianos de Bethesda III.